David McIntosh: Preventable Maternal and Newborn Deaths – The Urgent Need for Action
David McIntosh, Founder and Chair of United Plasma Action, shared Coalition for Women’s Health in Africa (COWHA)’s post on LinkedIn:
“Now here’s a terrifying thought…
We call this ‘the modern world’…”
Coalition for Women’s Health in Africa (COWHA) shared a post on Linkedin:
“Every year, millions of women, newborns, and babies die from causes that are preventable with timely, quality care.
The scale of the challenge is stark: approximately 260,000 women die each year from pregnancy and childbirth-related causes, alongside 2.3 million newborn deaths and 1.9 million stillbirths.
The greatest burden continues to fall on settings where proven and affordable interventions do not consistently reach those who need them most.
The challenge, therefore, is not simply knowing what works.
It is ensuring that proven solutions are financed, accessible, delivered at the right time, and integrated into health systems that can sustain them.
At the Coalition for Women’s Health in Africa (COWHA), we bring together governments, the private sector, and development partners across Kenya, Ghana, Nigeria, and South Africa to advance practical solutions for stronger, more equitable women’s and newborn health systems.
The evidence exists.
The interventions exist.
What is needed is sustained investment, stronger systems, and partnerships that can move solutions from evidence to implementation and scale.
Building healthier futures for women and newborns requires action across the health system.

Stay updated with Hemostasis Today.
-
Nov 20, 2026, 17:27Adam Bryant: Great Science, Valuable Connections and a Wonderful Haematology Community at Blood 2026
-
Nov 20, 2026, 17:25Gurpreet Kaurr: Scientific Discussions, New Perspectives and Inspiration at HAEMATOCON 2026
-
Nov 20, 2026, 17:24Bispecific FVIIIa-Mimetic Antibodies in Haemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Nov 20, 2026, 17:23Khalid Rehman: Psychosocial Burden Among Caregivers of Patients with Beta-Thalassemia Major in Pakistan
-
Nov 20, 2026, 17:20Dhinesh Selvaraju: Caplacizumab Becomes the First FDA-Approved Treatment for Pediatric aTTP
-
Nov 20, 2026, 17:19Paris Margaritis: Presenting Preclinical Data on GENV-HEM at the WFH Workshop
-
Nov 20, 2026, 17:18WFH Opens Public Comment on Draft Guidelines for Hemostatic Agents and Prophylaxis
-
Nov 20, 2026, 17:18Ketan Asawale: Consensus on the Management of Cancer-Associated Thrombosis in India
-
Nov 20, 2026, 17:16Ajay Samkaria: The Evolution of Hemostasis Diagnostics with the ACL TOP 70 Series